title: Return to play in the athlete with cardiac disease: who decides and what is the protocol?
abstract: Improved public awareness and advances in medical diagnostics have resulted in the development of criteria to determine eligibility or disqualification for the athlete with cardiovascular abnormalities. Simultaneously, protocols have been developed for athletes with concussion or orthopaedic injuries to guide team physicians and consultants in return-to-play decisions. However, there are currently inadequate data to allow the development of such protocols for athletes with cardiovascular abnormalities who have undergone treatment. Further complicating the decision process is the designation of the team physician as the ultimate authority in making return-to-play decisions - where the team physician often is an employee of the team and supports the team's goal and players as well as the individual athlete. This review will discuss the ethical dilemma of the team physician and the role of the cardiovascular consultant. Following this, current data and practices regarding return to play will be discussed for the following conditions or diagnoses: following catheter ablation for supraventricular tachycardia; following pacemaker or implantable cardioverter-defibrillator implantation; unexplained syncope; and the athlete with a genetic mutation in the absence of any phenotype of associated disease. These recommendations will undoubtedly continue to evolve and improve and should be considered at this time as a point of departure.
authors.affiliation: Division of Cardiology,Children's Hospital Los Angeles,Keck School of Medicine,University of Southern California,Los Angeles,California,United States of America.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Silka
mesh_terms: D056352:Athletes; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D017147:Defibrillators, Implantable / Q000009:adverse effects; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D010138:Pacemaker, Artificial / Q000009:adverse effects; D010820:Physicians / Q000941:ethics*; D017410:Practice Guidelines as Topic; D000068958:Return to Sport / Q000592:standards*; D013575:Syncope / Q000209:etiology
keywords: Return to play; athletic competition; sports competition; sudden cardiac death